|
HS Code |
916519 |
| Product Name | Hepta-6-Bromo-6-Deoxy-β-Cyclodextrin |
| Chemical Formula | C42H63Br7O28 |
| Molecular Weight | 1786.06 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water, DMSO, methanol |
| Purity | ≥95% (HPLC) |
| Cas Number | 174502-53-9 |
| Storage Temperature | 2-8°C |
| Degree Of Substitution | 7 (per cyclodextrin molecule) |
| Synonyms | Per-6-bromo-6-deoxy-β-cyclodextrin |
| Application | Supramolecular chemistry, host-guest studies, pharmaceutical research |
As an accredited Hepta-6-Bromo-6-Deoxy-Β-Cyclodextrin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Hepta-6-Bromo-6-Deoxy-Β-Cyclodextrin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Most people in the lab know β-cyclodextrin from their early days in chemistry, usually as a sugar ring that binds up small molecules. Those little barrels find their way into everything from academic separation experiments to drug delivery tricks. For years, I’ve watched researchers push at the edges, adding this or that to the rim of the ring to tune the whole system. Then along came hepta-6-bromo-6-deoxy-β-cyclodextrin. Immediately, hands-on chemists recognized something important—the addition of bromine changes the way this cyclodextrin behaves, converts an ordinary binder into a springboard for more advanced synthetic work.
Modifying β-cyclodextrin at the primary 6-position—swapping hydroxyls for bromides—decisively shapes its chemistry. Bromine, bulky and electron-rich, sits right where many reactions want to take place. That improves selectivity in substitution reactions. Instead of a forest of possibilities, synthetic chemists pull products with fewer side-branches and less mess to clean up. The deoxy tweak at the 6-position—removing the original hydroxyl—also slows down hydrolysis, which means the molecule stays intact through testing steps and extended storage.
In practice, I’ve seen the 6-bromo derivative unlock reactions that won’t run cleanly with native β-cyclodextrin. For example, nucleophilic substitution gets much more straightforward when bromo takes the place of that stubborn primary alcohol. Lab groups interested in chain building or attaching other functional handles find far less interference. The difference might sound subtle on paper, but from a practical bench perspective, the time and cost savings quickly add up.
Hepta-6-bromo-6-deoxy-β-cyclodextrin means all seven glucopyranose units around the cyclodextrin ring feature a bromo group instead of a hydroxyl at the 6-position. This brings a set of chemical properties not found in typical β-cyclodextrin, namely a solid increase in molecular mass and pronounced reactivity at every primary rim. The molecular formula, C42H56Br7O28, hints at the jump in weight and density. Unlike some of the less-substituted derivatives, this compound takes on uniformity around the entire ring, so every primary side speaks the same chemical language.
I’ve always appreciated that with a fully substituted system like this, planning the next step is less a gamble. The regularity makes it easier for colleagues to predict reaction outcomes when scaling up from milligrams to kilos, whether that’s for academic curiosity or more applied pursuits.
At first glance, a cyclodextrin loaded with bromides might seem like overkill. Critically, though, the bromo leaving group at the 6-position transforms the classic cyclodextrin into a chameleon. Need to anchor a bulky peptide or fluorescent label? Those bromo atoms serve as perfect launching pads for making advanced derivatives through SN2 pathways. Want to introduce amines, thiols, or azides? The substrate accommodates those swaps in a way the unmodified sugar ring won’t tolerate. That saves time, avoids redissolving and reprocessing steps, and reduces side reactions.
Colleagues working on targeted drug carriers or enzyme protection routinely face hurdles attaching the right payload at just the right place on a cyclodextrin. The uniformity brought by hepta-6-bromo-6-deoxy-β-cyclodextrin makes assay results far more reproducible and cuts down the batch variability that plagues research with minimally substituted rings. You get the flexibility to diversify your portfolio of β-cyclodextrin derivatives without returning to square one every time a new application crops up.
Traditional β-cyclodextrin works out of the box for many tasks requiring neutral, water-soluble molecular hosts. It’s a mainstay in food science and classic pharma projects looking to encapsulate and shield small molecules. But ask anyone who has had to functionalize the molecule’s edge—the primary 6-hydroxyls are stubborn partners, resisting selective modification and leading to a scrambled mix of products.
Hepta-6-bromo-6-deoxy-β-cyclodextrin solves that baseline roadblock. By swapping bromo for hydroxyl across every primary position, chemists aren’t forced to use harsh conditions or multi-step protection protocols. I watched many students stall out on per-alkylation or per-acylation projects because native cyclodextrins simply don’t cooperate. With the hepta-6-bromo variant, standard nucleophilic substitution techniques open up new chemical space. Adding variety to the cyclodextrin rim doesn’t have to mean weeks spent re-running columns or chasing off-target byproducts.
The story gets more interesting as researchers draw on the unique properties of this bromo derivative. Its increased hydrophobicity, compared to native β-cyclodextrin, comes in handy when preparing inclusion complexes with hydrophobic guest molecules. The molecule’s rim—now lined with bromo groups—offers a distinct fit, shifting the complexation profile and letting scientists explore new guest-host pairs.
Colleagues advancing imaging agents favor this system for tethering fluorescent dyes or radioisotope chelators. The reliability of substitution means cleaner products, crucial for diagnostics and tracing studies. Synthetic chemists see a gateway to build libraries of cyclodextrin-based conjugates, with each new derivative anchored to the primary rim. The pharmaceutical world, ever eager for new solubilizers or slow-release carriers, finds that the altered chemical landscape broadens what molecules can hitch a ride with minimal downstream cleanup.
Environmental scientists tapping cyclodextrins for pollutant trapping run trials with the bromo derivative to experiment with surface modifications. A bromo leaving group at every opening lets them tune interaction with pollutants, water, or materials for novel filtration and detection devices. The fact that the 6-deoxy motif slows breakdown in hostile environments only expands these applications further.
A big shift underway in cyclodextrin chemistry is the movement from ‘one size fits all’ to genuinely tailored functional platforms. Hepta-6-bromo-6-deoxy-β-cyclodextrin acts not just as a host, but as a scaffold. Instead of tweaking one corner and hoping for the best, chemists get a reliable basis for sevenfold substitution—turning the molecule into a focal point for multi-arm constructs. This accelerates projects involving dendrimers, star polymers, or multifunctional sensors. Every bromide substitution sets the scene for adding carboxyls, amines, or fluorescent tags in parallel.
With many other cyclodextrin derivatives, heterogeneity creeps in. Uncontrolled reactions scatter substituents around the ring in unpredictable ways. Come time to characterize the product, confusion over composition breeds delays and even regulatory headaches if the product sees downstream pharmaceutical use. Full substitution at the 6-position, matched across all glucopyranose units, gives a degree of structural clarity unmatched in less-modified products.
Bringing this modified β-cyclodextrin into the lab doesn’t demand exotic storage. It keeps in dry, cool conditions much as you would expect for most specialty organics. The deoxy backbone and stable bromo groups allow for longer shelf-lives, letting groups stock up without worrying about rapid degradation. That reliability helps avoid panic orders or wasted budget when a grant or contract pushes a project timeline out by months.
Handling the powder doesn’t involve anything out of the ordinary for experienced researchers familiar with halogenated organics. Protective equipment, good fume hoods, and careful weighing are enough to keep operations running safely in R&D or pilot-scale settings. Teams comfortable working with bromo reagents will find little new to adapt to.
Analytical chemists dig the clear mass spec signatures and sharp NMR shifts delivered by this kind of uniform modification. In the past, one pain point in cyclodextrin research centered on ambiguous spectra, with a mess of similar signals crowding out clean assignment. Swap in seven bromo atoms, and peaks spread out—much easier to assign. I’ve watched peers cut days out of their workflow, especially when batch-testing samples or publishing data. Reproducibility jumps up, and review processes run smoother.
While single-substituted or random substitution patterns might seem attractive for certain applications, the hepta-6-bromo approach brings cohesiveness to both synthesis and final analysis. That’s a bonus that often goes unappreciated until a regulatory agency or publication referee asks for proof of composition.
One aspect worth pausing over is this product’s contribution to cleaner synthetic strategies. By making selective modifications at the cyclodextrin periphery easier and more predictable, teams cut down substantially on byproduct generation. That translates into less solvent use, fewer chromatography runs, and reduced energy consumption in purification steps. Many labs today face strict constraints on solvent disposal and must show ways they’re reducing hazardous waste. In my experience, projects based on hepta-6-bromo-6-deoxy-β-cyclodextrin fit those targets comfortably—it’s just more efficient process chemistry.
In a field grappling with the environmental costs of advanced materials, this is no small feat. I’ve seen institutional safety committees breathe easier when the route to the final product involves fewer nasty side reactions and less cleanup.
Anyone with more than a passing familiarity with carbohydrate chemistry knows the minefield that is selective hydroxyl substitution. For β-cyclodextrin, scrambling to attach different arms at each primary hydroxyl leads to a population of mixed products. Even advanced protecting group strategies can’t completely prevent this. The hepta-6-bromo architecture circumvents the tedious protection and deprotection cycles—chemists gain a reliable, one-step pathway to install new functional groups at defined sites.
Graduate students tell me all the time: they’d rather tackle nuanced synthetic problems than grind through repetitive, error-prone protection chemistry. This derivative supports that focus. Teams iterate new designs faster, screen analogs in parallel, and generate data that stands up to peer review.
Hepta-6-bromo-6-deoxy-β-cyclodextrin has already started to influence how synthetic chemists and materials scientists approach functionalized hosts. Its reliable platform encourages interdisciplinary work. Whether designing targeted delivery vehicles in pharma, building nanomaterials, or advancing environmental remediation, this compound enables collaboration between groups that used to operate in isolation. Medicinal chemists benefit from higher-purity linkers, while physicists and engineers take advantage of the molecule’s symmetry for self-assembly experiments.
Academic collaborations benefit, too. Shared reference materials and transparent analytical profiles mean labs in different countries or on separate continents can trade insights and know they’re seeing the same chemistry in action. That trust speeds progress and plugs knowledge gaps between subfields.
Like any specialized tool, hepta-6-bromo-6-deoxy-β-cyclodextrin works best in informed hands. Mishandled bromide sources can lead to waste or, worse, off-target reactivity if synthetic steps go poorly planned. Early on, a few overzealous attempts to drive substitutions too hard produced undesired elimination or side reactions—so careful monitoring and methodical reaction planning remain key.
There’s no shortcut for experience here. Successful projects start with a grounding in both classic cyclodextrin behavior and the nuances the new substitution pattern enables. Cross-training with halogen chemistry, nucleophilic substitution routes, and advanced analytical techniques pays dividends. I always encourage early-career chemists to consult the literature and seek out colleagues with hands-on practical expertise before scaling up or shifting to high-value payloads.
With the all-bromo rim, some users worry about long-term risks or environmental hazards. Regular review of published toxicological and regulatory data remains a must, as is consulting with institutional safety managers before running new large-scale syntheses. The good news—unlike many legacy halogenated compounds, this material’s stability and low volatility substantially reduce workplace exposures. For bench chemists used to working with bromo-organics and a well-run fume hood, it adds no unusual risk.
The hepta-6-bromo approach doesn’t just solve existing problems in cyclodextrin modification. It opens wide doors to entirely new areas in supramolecular chemistry, materials science, and pharmaceutical delivery. As the search for sustainable, efficient, and precise molecular hosts continues, this compound puts broader, cleaner synthetic pathways within reach.
For labs willing to invest in advanced functionalization chemistry, the arrival of this uniformly substituted cyclodextrin shortens the journey from proof-of-concept to finished material. That means more focus on breakthroughs, fewer setbacks from stubborn side-reactions, and a better shot at making real-world impact across sectors.
Having watched the progress from basic β-cyclodextrin to the bromo-loaded variant, I’m convinced we’re just beginning to see the potential this platform offers. From new catalysts and self-assemblies to specialty carriers for tomorrow’s medicines, the reliable, versatile rim of hepta-6-bromo-6-deoxy-β-cyclodextrin brings those ambitions closer to reality.